https://medicine.ouhsc.edu/academic-departments Parent Page: Academic Departments id: 22046 Active Page: Faculty - Staffid:22079

Faculty and Staff

Faculty

Rosemary Zuna, MD
Pathology

Rosemary Zuna, MD

Section Head, Gynecologic Pathology

Professor of Pathology


OU Medical Center
Everett Tower
800 N.E. 13th
Room 3ANP522
Oklahoma City, Oklahoma  73117

405-271-5507

rosemary-zuna@ouhsc.edu


Education:

Jefferson Medical College
M.D. - Medicine (1972)


Clinical/Research Interests:

  • Research Interest:
    • HPV-associated carcinogenesis
  • Sub-Specialty
    • Gynecologic Pathology
    • Cytopathology


Select Publications:

  1. Landrum LM, Nugent EK, Zuna RE, Syzek E, Mannel RS, Moore KN, MD,Walker JL, McMeekin DS: Phase II trial of vaginal cuff brachytherapy followed by chemotherapy in early stage endometrial cancer patients with high-intermediate risk factors. Gynecol Oncol. 2014 Jan;132(1):50-4. PMID: 24219982 

  2. Sahasrabuddhe VV, Gravitt PE, Dunn ST, Brown D, Allen RA, Smith K, Zuna RE, Zhang RR, Gold MA, Schiffman M, Walker JL, Castle PE, Wentzensen N: Comparison of HPV detection in urine, vulvar, and cervical samples from women attending a colposcopy clinic. J Clin Microbiol. 2014 Jan;52(1):187-92. Epub 2013 Nov 6. doi:10.1128/JCM.01623-13. PMID: 24197879  

  3. Zhao L, Wentzensen N, Dunn ST, Gold MA, Wang SS, Schiffman M, Walker JL, Zuna RE. Factors associated with reduced accuracy in Papanicolaou tests for patients with invasive cervical cancer. Cancer Cytopathol. 2014 May 28. doi: 10.1002/cncy.21443. PMID:24888458. (Article was selected to be featured on journal cover)  

  4. Wentzensen N, Walker JL, Gold MA, Smith KM, Zuna RE, Mathews C, Dunn ST, Zhang R, Moxley K, Bishop E, Tenney M, Nugent E, Wacholder S, Schiffman M. Multiple biopsies improve detection of cervical cancer precursors at colposcopy. J Clin Oncol. 2015 Jan 1;33(1):83-9. Epub 2014 Nov 24. doi: 10.1200/JCO.2014.55.9948. PMID: 25422481.  

  5. den Boon JA, Pyeon D, Wang SS, Horswill M, Schiffman M, Sherman M, Zuna RE, Wang Z, Hewitt SM, Pearson R, Schott M, Chung L, He Q, Lambert P, Walker J, Newton MA, Wentzensen N, Ahlquist P. Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling. Proc Natl Acad Sci U S A. 2015 Jun 23;112(25):E3255-64. doi: 10.1073/pnas.1509322112. Epub 2015 Jun 8. PMID: 26056290.

  6. Guo P, Almbarak H, Banerjee K, Stanley RJ, Long R, Antani S, Thoma G, Zuna R, Frazier S, Moss R, Moss RH, Stoecker WV. Enhancements in localized classification for uterine cervical cancer digital histology image assessment. J Pathol Inform. 2016; 7:51. (30 December 2016) doi: 10.4103/2153-3539.197193. (Journal not currently indexed for MedLine)
  7. Schiffman M, Yu K, Zuna R, Dunn T, Zhang H, Walker J, Gold M, Hyun N, Rydzak G, Katki H, Wentzensen N. Proof-of-principle study of a novel cervical screening strategy: computer-analyzed cytology to decide which HPV-positive women are likely to have >CIN2. Int J Cancer [Epub ahead of print] 2016 Oct 1. doi: 10.1002/ijc.30456. 2017 Feb 1;140(3):718-725. PMID: 27696414
  8. The Cancer Genome Atlas Research Network …. Zuna R .... Integrated and molecular characterization of cervical cancer. Nature. 2017. Mar 16;543(7645):378-384 [Epub ahead of print] Jan 23. doi: 10.1038/nature21386. PMID:28112728

  9. Cherniak A, Shen H, Walter VA, Stewart C, Murray B, Bowlby R, Hu X, Ling S, Soslow R, Broaddus R, Zuna RE, Robertson G, Laird P, Kucherlapati R, Mills GB, The Cancer Genome Atlas Research Network, Weinstein JN, Zhang J, Akbani R, Levine D. Integrated molecular characterization of uterine carcinosarcoma. Cancer Cell. 2017 Mar 13;31(3):411-423. doi: 10.1016/j.ccell.2017.02.010. PMID:28292439

  10. Rader JS, Sill MW, Beumer JH, Lankes HA, Benbrook DM, Garcia F, Trimble C, Tate Thigpen J, Lieberman R, Zuna RE, Leath CA, Spirtos NM, Byron J, Thaker P, Shashikant L, Alberts DA. Stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: the predictive value of VEGF serum levels: an NRG Oncology/Gynecologic Oncology Group Study. Gynecol Oncol. 2017 May;145(2):291-297. doi: 10.1016/j.ygyno.2017.02.040. Epub 2017 Mar 10. PMID: 28285845



Adjunct Faculty

Sepideh Nikki Asadbeigi, MD

Sepideh N Asadbeigi, MD

Assistant Professor - Pathology

Dermatopathology

Adjunct Faculty - Dermatology

Prabir K. Chakraborty, PhD

Prabir K. Chakraborty, PhD

Assistant Professor (Research)

Daniel J. Cowden, MD, FCAP, CPHIMS

Daniel J. Cowden, MD, FCAP, CPHIMS

Clinical Associate Professor

Charles Esmon, PhD

Charles Esmon, PhD

Lloyd Noble Chair, Cardiovascular Research

Member & Head, Cardiovascular Biology Research at OMRF

Adjunct Professor, Pathology

Adjunct Professor, Biochemistry

Investigator at Howard Hughes Medical Institute

David M Lewis, DDS

David M. Lewis, DDS

Associate Professor
Department of Oral and Maxillofacial Pathology

Adjunct Associate Professor
Department of Pathology

Jeffrey McBride, MD, PhD

Jeffrey McBride, MD, PhD

Assistant Professor

Director of Dermatopathology

Adjunct Faculty - Pathology

Charles A. Montgomery, DVM, DACVP, DACLAM

Charles A. Montgomery, DVM, DACVP, DACLAM

Adjunct Professor
Department of Pathology
Division of Comparative Medicine

Kathy L. Moser, PhD

Kathy L. Moser, PhD

Associate Member, Arthritis & Immunology Program
OMRF

Adjunct Faculty, Pathology

Amr H. Sawalha, MD

Amr H. Sawalha, MD

Assistant Member
Arthritis and Immunology Research Program

Assistant Professor of Medicine 
Department of Medicine

Staff Physician 
Veteran Affairs Medical Center
Oklahoma City

Adjunct Faculty
Department of Pathology